Cargando…
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
The time point of the most precise predictor of hepatocellular carcinoma (HCC) development after viral eradication with direct-acting antiviral (DAA) therapy is unclear. In this study we developed a scoring system that can accurately predict the occurrence of HCC using data from the optimal time poi...
Autores principales: | Watanabe, Takao, Tokumoto, Yoshio, Joko, Kouji, Michitaka, Kojiro, Horiike, Norio, Tanaka, Yoshinori, Hiraoka, Atsushi, Tada, Fujimasa, Ochi, Hironori, Kisaka, Yoshiyasu, Nakanishi, Seiji, Yagi, Sen, Yamauchi, Kazuhiko, Higashino, Makoto, Hirooka, Kana, Morita, Makoto, Okazaki, Yuki, Yukimoto, Atsushi, Hirooka, Masashi, Abe, Masanori, Hiasa, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238506/ https://www.ncbi.nlm.nih.gov/pubmed/37268672 http://dx.doi.org/10.1038/s41598-023-36052-0 |
Ejemplares similares
-
AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
por: Watanabe, Takao, et al.
Publicado: (2021) -
Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients
por: Watanabe, Takao, et al.
Publicado: (2016) -
Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018) -
Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
por: Nakamura, Yoshiko, et al.
Publicado: (2023) -
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
por: Ochi, Hironori, et al.
Publicado: (2020)